- Home
- AVIR vs GDEV Comparison
AVIR vs GDEV Comparison
Compare AVIR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- GDEV
- Stock Information
- Founded
- AVIR 2012
- GDEV 2009
- Country
- AVIR United States
- GDEV Cyprus
- Employees
- AVIR N/A
- GDEV N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- GDEV EDP Services
- Sector
- AVIR Health Care
- GDEV Technology
- Exchange
- AVIR Nasdaq
- GDEV Nasdaq
- Market Cap
- AVIR 290.4M
- GDEV 266.7M
- IPO Year
- AVIR 2020
- GDEV N/A
- Fundamental
- Price
- AVIR $3.14
- GDEV $32.27
- Analyst Decision
- AVIR Hold
- GDEV
- Analyst Count
- AVIR 1
- GDEV 0
- Target Price
- AVIR $6.00
- GDEV N/A
- AVG Volume (30 Days)
- AVIR 399.6K
- GDEV 22.9K
- Earning Date
- AVIR 11-06-2025
- GDEV 11-13-2025
- Dividend Yield
- AVIR N/A
- GDEV 9.97%
- EPS Growth
- AVIR N/A
- GDEV 12.96
- EPS
- AVIR N/A
- GDEV 2.56
- Revenue
- AVIR N/A
- GDEV $425,112,000.00
- Revenue This Year
- AVIR N/A
- GDEV N/A
- Revenue Next Year
- AVIR N/A
- GDEV $1.39
- P/E Ratio
- AVIR N/A
- GDEV $12.96
- Revenue Growth
- AVIR N/A
- GDEV N/A
- 52 Week Low
- AVIR $2.46
- GDEV $8.60
- 52 Week High
- AVIR $4.02
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- AVIR 52.91
- GDEV 60.45
- Support Level
- AVIR $2.78
- GDEV $33.28
- Resistance Level
- AVIR $2.94
- GDEV $42.20
- Average True Range (ATR)
- AVIR 0.10
- GDEV 6.31
- MACD
- AVIR 0.04
- GDEV 0.60
- Stochastic Oscillator
- AVIR 90.79
- GDEV 54.36
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.